|
⚲
|
| Keyboard |
| Aballi John
✚
|
|
|---|---|
| CIK # | 0001843113 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001843113] | |
| 4 | [0001843113] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Exagen Inc | |
| Aballi John |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Exagen Inc XGN
Common Stock
|
2026-03-12 | Grant | 150,000 | $0.00 | |
|
Exagen Inc XGN
Stock Option(right to buy) · derivative
|
2026-03-12 | Grant | 100,000 | $3.16 | 316,000 |
|
Exagen Inc XGN
Common Stock
|
2026-03-03 | Sell | 15,698 | $3.62 | 56,827 |
|
Exagen Inc XGN
Common Stock
|
2026-03-03 | Grant | 2,535 | $3.08 | 7,808 |
|
Exagen Inc XGN
Common Stock
|
2026-02-24 | Sell | 11,430 | $3.61 | 41,262 |
|
Exagen Inc XGN
Common Stock
|
2025-10-16 | Sell | 31,787 | $11.82 | 375,722 |
|
Exagen Inc XGN
Common Stock
|
2025-02-28 | Grant | 8,621 | $2.47 | 21,294 |
|
Exagen Inc XGN
Stock Option(right to buy) · derivative
|
2025-02-21 | Grant | 75,000 | $3.58 | 268,500 |
|
Exagen Inc XGN
Common Stock
|
2025-02-21 | Grant | 112,500 | $0.00 | |
|
Exagen Inc XGN
Common Stock
|
2024-11-14 | Buy | 24,305 | $2.81 | 68,297 |
|
Exagen Inc XGN
Common Stock
|
2024-05-16 | Buy | 40,401 | $1.92 | 77,570 |
|
Exagen Inc XGN
Common Stock
|
2024-02-29 | Grant | 9,804 | $1.91 | 18,726 |
|
Exagen Inc XGN
Common Stock
|
2024-02-20 | Grant | 175,000 | $0.00 | |
|
Exagen Inc XGN
Common Stock
|
2023-10-17 | Sell | 33,819 | $1.75 | 59,183 |
|
Exagen Inc XGN
Common Stock
|
2023-08-31 | Grant | 9,803 | $2.14 | 20,978 |
|
Exagen Inc XGN
Common Stock
|
2022-12-08 | Buy | 90,000 | $2.68 | 241,200 |
|
Exagen Inc XGN
Restricted Stock Units
|
2022-10-16 | Grant | 350,000 | $0.00 |